Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report) rose 3% during mid-day trading on Tuesday . The stock traded as high as $0.21 and last traded at $0.21. Approximately 322,085 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 552,332 shares. The stock had previously closed at $0.2039.
Azitra Price Performance
The company’s 50 day simple moving average is $0.22 and its 200-day simple moving average is $0.26.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.24). On average, equities analysts forecast that Azitra, Inc. will post -0.71 EPS for the current year.
About Azitra
Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.
The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.
Further Reading
- Five stocks we like better than Azitra
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
